Translational medicine in psychiatry: challenges and imaging biomarkers

Abstract Among research disciplines, neuroscience has introduced the most fundamental changes in the way in which mental disease states are conceptualized and pursued. Nowhere is this more obvious than in translational medicine. The slow, arduous empirical process of finding new treatments must be properly incentivized for this work to be done by the current and next generation of psychiatric neuroscientists. Here, the toolboxes such as evolving biomarkers (e.g., imaging, transomic and functional biomarkers) genetics are discussed in relation to translational issues in mental diseases.